Markets Stocks Economy Crypto Earnings Banking Energy
Home› Markets› Feature
Markets · Exclusive

European ADRs slide 1.5% as SAP, Novo Nordisk lead declines

European ADRs slide 1.5% as SAP, Novo Nordisk lead declines
Markets · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Nov 17, 2026 3 min read

US investors holding European stocks through American depositary receipts (ADRs) saw those shares slide Tuesday morning, as the S&P Europe Select ADR Index fell 1.49% to 1,833.26. The decline was led by some of the region's biggest names, including enterprise software giant SAP and Danish drugmaker Novo Nordisk.

What are ADRs and why do they matter?

ADRs are certificates that allow US investors to trade shares of foreign companies on American exchanges, in US dollars, during regular US market hours. They function as a convenient proxy for overseas markets, especially when local European exchanges are closed. Because they trade in real time, they often act as a quick gauge of investor sentiment toward Europe.

Tuesday's move was broadly risk-off. SAP, the German software company, dropped 4.5%, while Novo Nordisk, the Denmark-based pharmaceutical firm known for its weight-loss and diabetes drugs, fell 2.7%. Other notable decliners included medical-device maker EDAP TMS, which slid 6.3%, and browser company Opera, which lost 5.7%.

Not every stock moved lower. France-based biotech Cellectis was among the few gainers, though the overall tone was clearly negative.

What's behind the slide?

The brief doesn't specify a single catalyst, but the breadth of the decline suggests investors were in a risk-off mood. European equities have been sensitive to a range of factors recently, including shifts in the AI trade, central bank policy expectations, and geopolitical developments. The drop in SAP, a major software and cloud player, could reflect concerns about tech valuations or spending, while Novo Nordisk's decline might be tied to sector-specific news or broader healthcare sentiment.

It's also worth noting that ADR moves can be amplified by currency fluctuations. When the dollar strengthens against the euro or other European currencies, ADR prices in dollars can fall even if the underlying stock is flat in local terms. That dynamic can add noise to daily readings.

What it means for investors

For everyday investors, a single day's ADR move shouldn't be overinterpreted. ADRs are a convenient way to diversify internationally, but they come with their own risks, including currency exposure and sometimes lower liquidity than domestic stocks.

Tuesday's slide is a reminder that European markets can be volatile, and that sentiment can shift quickly. Investors with broad international exposure may want to keep an eye on how European indices and major ADRs perform over the coming days, especially if the decline extends.

The drop also comes amid a period of mixed signals for European equities. While some companies have reported rebounds in European demand, others have faced headwinds from specific corporate news. The broader picture remains one of uncertainty, with investors weighing interest rate expectations, inflation data, and the health of the global economy.

Looking ahead

Investors will likely watch whether the decline in European ADRs continues into the afternoon session and whether it spills over into US markets. The S&P Europe Select ADR Index is a useful barometer, but it's not the whole story. Individual stocks can diverge significantly from the index, as seen with Cellectis's gain.

For those holding ADRs, it's worth remembering that these instruments track foreign companies, so their performance is tied to both the underlying business and the currency exchange rate. A diversified portfolio that includes international exposure can benefit from ADRs, but it's important to understand the risks.

As always, the best approach is to stay informed and avoid making hasty decisions based on a single day's market move. Tuesday's slide is a reminder that markets can be unpredictable, but for long-term investors, short-term fluctuations are often just noise.

More from this story

Next article · Don't miss

TPG in talks to take BILL Holdings private, Reuters reports

TPG is in talks to take BILL Holdings private, potentially at a premium, after activist investors pushed for changes. The news sent BILL shares up nearly 13% to a 52-week high.

Read the story →
TPG in talks to take BILL Holdings private, Reuters reports